Page 63 - InsideOut Magazine

NewProducts Available from ASD Healthcare
ASD Healthcare is now an authorized distributor for several new products, which are described below. We continuously expand our product lines to make sure you have access to the products you need, when you need them. To verify a product is appropriate for your facility to order, simply call your sales representative. We’re always here to help you.
Ne
Beleodaq
Manufactured by Spectrum Pharmaceuticals, Inc., Beleodaq® is indicated for the treatment of patients with relapsed or refractory peripheral T-Cell lymphoma (PTCL).
For specific product information, please see page 70 in our Product Catalog.
Blincyto
Manufactured by Onyx Pharmaceuticals, Blincyto® is indicated for patients with Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukemia (B-cell ALL) and uncommon form of ALL.
For specific product information, please see page 70 in our Product Catalog.
Ibrance (palbociclib)
Manufactured by Pfizer, Ibrance® (palbociclib) is indicated for the treatment of advanced breast cancer, and is intended to be used with the FDA- approved breast cancer treatment Letrozole®. For specific product information, please see page 70 in our Product Catalog.
Keytruda Liquid
Manufactured by Merck, the new liquid version of Keytruda® (pembrolizumab) for injection, for IV infusion, is indicated for the treatment of pa- tients with unresectable or metastatic melanoma and disease progression following ipilimumab. For specific product information, please see page 71 in our Product Catalog.
NovoEight
Manufactured by Novo Nordisk, NovoEight® is an antihemophilic factor recombinant indicated for use in adults and children with Hemophilia A, to control and prevent bleeding episodes, peri- operative management and routine prophylaxis. NovoEight is not indicated for the treatment of von Willebrand disease.
For specific product information, please see page 65 in our Product Catalog.
Omidria
Manufactured by Omeros, OmidriaTM is used during cataract surgery or intraocular lens replacement and is indicated for maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain.
For specific product information, please see page 73 in our Product Catalog.
Opdivo
Manufactured by Bristol-Myers Squibb, Opdivo® is a new treatment indicated for patients with unresectable or metastatic mela- noma that no longer responds to other drugs. For specific product information, please see page 71 in our Product Catalog.
Paricalcitol Injection
Manufactured by Hospira, Paricalcitol Injection is an active vitamin D2 analog indicated for
the prevention and treatment of secondary hyperparathyroidism associated with chronic kidney disease Stage 5.
For specific product information, please see page 85 in our Product Catalog.
Rapivab
Manufactured by BioCryst Pharmaceuticals, Inc., RapivabTM is the first and only one dose IV treatment for flu. It is indicated for the treatment of acute, uncomplicated influenza in patients 18 years and older who have been symptomatic for more than two days.
For specific product information, please see page 73 in our Product Catalog.
RegenKit BCT
Manufactured by RegenLab USA, RegenKit® BCT is a kit designed to prepare autologous- platelet rich plasma from a small sample of the patient’s own blood. Platelets are key factors in hard and soft tissue repair.
For specific product information, please see page 73 in our Product Catalog.
ASD Healthcare | 61
For quick and updated product information on our most popular products, including these new products, please see our
Product Catalog on page 63.
w